SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2012 / Cilt: 42 - Sayı: 3

Th e seroprevalence of Rickettsia conorii in humans living in villages of Tokat Province in Turkey, where Crimean-Congo hemorrhagic fever virus is endemic, and epidemiological similarities of both infectious agents

Kırım Kongo hemorajik ateş virüsünün endemik olduğu Tokat’ın köylerinde yaşayan insanlarda Rickettsia conorii seroprevalansı ve her iki enfeksiyon etkeninin epidemiyolojik benzerlikleri

Turabi GÜNEŞ
Ömer POYRAZ
Mehmet ATAŞ -
Nergiz Hacer TURGUT
Pages
441–448
Publication Date
2012-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The overall prevalence of antibodies reactive with R. conorii was 36.81%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tokat Province is an epicenter for Crimean-Congo hemorrhagic fever virus (CCHFV) in Turkey.
📊
Key Findings & Data:Materials and methods: The prevalence of antibodies reactive with R. conorii was examined by ELISA in 364 sera, 151 of which were seropositive for CCHFV.
💡
Conclusion & Impact:Results: The overall prevalence of antibodies reactive with R. conorii was 36.81%.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Rickettsia conorii · Akdeniz benekli ateşi · seroprevalans

Abstract

Tokat Province is an epicenter for Crimean-Congo hemorrhagic fever virus (CCHFV) in Turkey. The aim of this study was to investigate the seroprevalence of Rickettsia conorii and to clarify the epidemiological similarities between CCHFV and R. conorii in Tokat Province. Materials and methods: The prevalence of antibodies reactive with R. conorii was examined by ELISA in 364 sera, 151 of which were seropositive for CCHFV. Results: The overall prevalence of antibodies reactive with R. conorii was 36.81%. The prevalence of antibodies to R. conorii infection was higher in humans who showed CCHFV seropositivity than seronegativity, 52.32% and 25.82%, respectively (P = 0.001). A significant difference in seroprevalence was found between groups who had a history of tick bite and who did not, 41.52% and 29.29%, respectively (P = 0.019). Conclusion: Our data show that people who are a risk group for CCHFV are likely to be a risk group for R. conorii.

Özet

Amaç: Tokat, Kırım-Kongo Hemorajik Ateş Virüsü (CCHFV) yönünden yüksek derece endemik bir yöredir. Buçalışmanın amacı, Tokat yöresinde Rickettsia conorii’nin seroprevalansını araştırmak ve CCHFV’ü ve Rickettsia conoriiarasındaki epidemiyolojik benzerlikleri ortaya koymaktır.Yöntem ve gereç: 151’i CCHFV’ü yönünden seropozitif olmak üzere, toplam 364 serum örneğinde ELISA yöntemi ileR. conorii ile reaktif antikorların prevalansı araştırılmıştır.Bulgular: R. conorii ile reaktif antikorların genel prevalansı % 36,81 olarak saptanmıştır. R. conorii enfeksiyonuna karşıoluşmuş antikor prevalansı, CCHFV seropozitifl iği olanlarda, seronegatifl ere göre daha yüksek tespit edilmiş olupsırasıyla % 52,32 ve % 25,82 oranlarında saptanmıştır (P = 0,001). Kene ısırığı öyküsü olanlarda % 41,52 ve olmayanlarda% 29,29 oranında görülmesiyle, gruplar arasında seroprevalans bakımından anlamlı bir farklılık bulunmuştur (P =0,019).Sonuç: Bulgularımız CCHFV yönünden risk grubundan olan insanların R. conorii yönünden de risk grubundanolmasının muhtemel olduğunu göstermiştir.

🔖

Cite This Article

GÜNEŞ, T., POYRAZ, Ö., -, M. A., TURGUT, N. H. (2012). Th e seroprevalence of Rickettsia conorii in humans living in villages of Tokat Province in Turkey, where Crimean-Congo hemorrhagic fever virus is endemic, and epidemiological similarities of both infectious agents. Turkish Journal of Medical Sciences, Cilt: 42 - Sayı: 3, 441–448. https://ajindex.com/articles/723504

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 2005; 18: 719-56. 2. Parola P and Raould D. Tick and tickborne bacterial diseases in humans: An emerging infectious threat. Clin Infect Dis 2001; 32: 897-928. Buckingham SC. Tick-borne infections in children. Pediatr Drugs 2005; 7: 163-176.
  2. Keysary A, Strenger C. Use of enzyme-linked immunosorbent assay techniques with cross-reacting human sera in diagnosis of murine typhus and spotted fever. J Clin Microbiol 1997; 35: 1034-5.
  3. La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997; 35: 2715-27. 6. Aydin L, Bakirci S. Geographical distribution of ticks in Turkey. Parasitol Res 2007; 101: 63-66.
  4. Kuloglu F, Rolain JM, Fournier PE, Akata F, Tugrul M, Raoult D. First isolation of Rickettsia conorii from human in the Trakya region (European part) of Turkey. Eur J Clin Microbiol Infect Dis 2004; 23: 609-14.
  5. Vural T, Ergin C, Sayin F. Investigation of Rickettsia conorii antibodies in the Antalya area. Infection 1998; 26: 170-72.
  6. Vatansever Z, Uzun R, Estrada-Pena A, Ergonul O. Crimean- Congo hemorrhagic fever in Turkey. In: Ergonul O, Whitehouse CA, eds. Crimean-Congo hemorrhagic fever: a global perspective. Amsterdam: Springer; 2007.
  7. Gunes T, Engin A, Poyraz O, Elaldi N, Kaya S, Dokmetas I et al. Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey. Emerg Infect Dis 2009; 15: 461-4. Gunes T. Crimean-Congo Hemorrhagic Fever. Mikrobiyol Bul 2006; 40: 279-87.
  8. Karaer F, Kılınç M, Kutbay HG. Th e woody vegetation of Kelkit Valley. Tr J of Botany 1999; 23: 319-44.
  9. Raoult D, Dupont HT, Chicheportiche C, Peter O, Gilot B, Drancourt M. Mediterranean spotted fever in Marseille, France: correlation between prevalence of hospitalized patients, seroepidemiology, and prevalence of infected ticks in three diff erent areas. Am J Trop Med Hyg 1993; 48: 249-56.
  10. Aharonowitz G, Koton S, Segal S, Anis E, Green MS. Epidemiological characteristics of spotted fever in Israel over 26 years. Clin Infect Dis 1999; 29: 1321-2.
  11. Raoult D, Weiller PJ, Chagnon A, Chaudet H, Gallais H, Casanova P. Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg 1986; 35: 845-50.
  12. Sousa R, Nobrega SD, Bacellar F, Torgal J. Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hosp